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A cost-eﬀective alternative approach capable of determining the prevalence of substance use in communities can
complement the existing eﬀorts of combating drug abuse and addiction. In this study, the prevalence of 10 illicit
and 19 prescribed psychoactive drugs of potential abuse was determined utilizing wastewater-based epidemiology, and compared in two adjoined urban communities and a rural community. This is the ﬁrst application
of the Monte Carlo simulation method to account multiple uncertainties and propagation of errors associated
with the individual parameter of wastewater based epidemiological estimations in the U.S. A signiﬁcantly higher
prevalence of cocaine [3830 (mean diﬀerence, MD: 2960) mg/d/1000 people] was found in the central business
district while the per-capita consumption rates of amphetamine [738 (MD: 338) mg/d/1000 people] and methamphetamine [1660 (MD: 629) mg/d/1000 people] were higher in a rural community. Among narcotics, the
per-capita consumption rate of fentanyl and morphine was signiﬁcantly higher in urban communities while
codeine, hydrocodone, hydromorphone, and buprenorphine were dominant in a rural community. The signiﬁcantly higher prevalence of buprenorphine (˜20-30 folds), oxycodone (˜2-3 folds), and alprazolam (˜2-3 folds)
determined in these communities compared to the conventional estimates based on the electronically reported
prescriptions and drug-related inpatient hospitalizations suggest the abuse of these drugs.

Keywords:
Illicit drugs
Wastewater-based epidemiology
Monte Carlo simulation
Ammoniacal-nitrogen-based-population
Drug consumption

⁎

Corresponding author at: Department of Chemistry, Murray State University, 1201 Jesse D. Jones Hall, Murray, KY 42071, United States.
E-mail address: bsubedi@murraystate.edu (B. Subedi).

https://doi.org/10.1016/j.jhazmat.2019.121306
Received 22 May 2019; Received in revised form 5 September 2019; Accepted 23 September 2019
Available online 24 September 2019
0304-3894/ © 2019 Elsevier B.V. All rights reserved.

Journal of Hazardous Materials 384 (2020) 121306

T.L. Croft, et al.

1. Introduction

The conventional population estimates such as a round-ﬁgure population provided by the WWTP personnel and a census-based estimate
does not account for the population dynamics such as population
growth, day-speciﬁc variability, day–night variability, and residents’
use of septic systems or straight-piping (Subedi, 2019). Therefore, de
jure population introduces one of the greatest uncertainties for WBE
estimation and consequently under- or overestimate the actual consumption (Been et al., 2014). The population dynamicity within WWTP
catchment has been typically estimated based on the hydrochemical
parameters (van Nuijs et al., 2011; Zheng et al., 2019), Bayesian Inference model incorporating the mass loads of chemical marker in
census day (O’Brien et al., 2014), endogenous or exogenous biomarkers
such as creatinine and 5-hydroxyindoleacetic acid (Brewer et al., 2012),
and geographical and time reference mobile call information (Thomas
et al. (2017)). Ammonia, a product of hydrolysis of urea, is a relatively
more selective human-derived biomarker in wastewater - used to determine a near-accurate population in WWTP catchments and examine
the diurnal variation in the prevalence of substance abuse in Switzerland (Been et al., 2014) as well as the trend in consumption of tobacco
(Zheng et al., 2017) and methamphetamine in China (Zheng et al.,
2019). There are very few studies that reported a statistical range of
consumption rates incorporating the associated uncertainties. For instance, Been et al. determined the consumption rates of three opioids
addressing uncertainties associated with ﬂow measurements, chemical
analysis, excretion, and adsorption of target drugs onto the suspended
particulates using Monte Carlo simulation (Been et al., 2016b). The
computational algorithm on WBE ﬁndings provided the close-agreement to the estimated load of morphine based on prescriptions and
sales data in Switzerland as well as the methamphetamine prevalence in
China compared to the oﬃcial report (Zheng et al., 2019). Lai et al.
(2011) also propagated the individual uncertainties associated with
sampling, chemical analysis, ﬂow measurements, excretion rates, and
population in the WWTP catchments (Lai et al., 2011).
Despite being considered one of the countries with the highest
prevalence of substance use, there are very few WBE studies reported in
the U.S. (Gushgari et al., 2018). To the authors’ knowledge, this is the
ﬁrst study utilizing Monte Carlo simulation to incorporate the uncertainties associated with the wastewater-based epidemiological determination of the prevalence of substance use in two relatively large
(> 150,000 population) urban and a rural (˜20, 000 population) communities in the U.S. The major objectives of this study were to (i) account for the uncertainties associated with the WBE using Monte Carlo
simulation, (ii) determine the prevalence of ten illicit drugs [cocaine,
amphetamine, methamphetamine, heroin, morphine, methadone, 3,4methylenedioxymethamphetamine
(MDMA),
3,4-methylenedioxyethylamphetamine (MDEA), 3,4-methylenedioxyamphetamine (MDA),
and Δ9-tetrahydrocannabinol (THC)] and nineteen neuropsychiatric
drugs (methylphenidate, codeine, fentanyl, oxycodone, hydrocodone,
hydromorphone, buprenorphine, quetiapine, aripiprazole, lorazepam,
alprazolam, diazepam, oxazepam, temazepam, carbamazepine, sertraline, ﬂuoxetine, venlafaxine, and citalopram) in urban communities,
(iii) compare the prevalence of substance uses between two adjoined
urban communities and that with a rural community, and (iv) compare
the WBE-derived prevalence of substance uses with the conventional
estimates. Moreover, the potential of three hydrochemical markers in
raw wastewater was evaluated to determine a near-real population
served by the WWTP.

The prevalence of substance uses and addiction is growing as a
global threat to social and economic well-being (United Nation Oﬃce
on Drugs and Crime, 2018). In the U.S., the ongoing opioid epidemic
was declared in 2017 as a national public health emergency, while
other drugs of abuse remain prevalent (U. S. Department of Health and
Human Services, 2019). For the ﬁrst time in half a century, the life
expectancy in the U.S. has declined in 2015 and 2016 with a key factor
being a rise in drug-related deaths. Therefore, the timely, cost-eﬀective,
and comprehensive measure of the prevalence of substance use has
never been more imperative before.
Wastewater-based epidemiology (WBE) is a fast-growing approach
for the estimation of consumption of a chemical substance in the
community as complementary to the conventional survey-based approaches (Foppe et al., 2018; O’Brien et al., 2019). WBE has been
exploited to estimate the consumption statistics of the illicit drugs
(European Monitoring Center for Drugs and Drug Addiction (EMCDDA),
2019; Australian Criminal Intelligence Commission (ACIC), 2019;
Subedi and Kannan, 2014; Burgard et al., 2019), potentially abused
prescribed drugs (Subedi et al., 2015; Skees et al., 2018), as well as
evaluate the human exposure to the classic persistent pollutants such as
pesticides (Rousis et al., 2017), emerging pollutants such as ﬂame retardants (Been et al., 2018) and phthalates (González-Mariño et al.,
2017; Du et al., 2018), and several other public health biomarkers such
as diet (Venkatesan et al., 2019), pathogenic bacteria (Fernandez-Cassi
et al., 2018), and virus (Prado et al., 2012). In WBE, the trace level of
drug biomarkers in raw wastewater is used to back-calculate the community consumption of drugs which can reveal the trend of drug consumption (Mastroianni et al., 2017) and the eﬀectiveness of the authorities’ eﬀorts to combat drug abuse (Li et al., 2019; Been et al.,
2016a).
Conventionally, the prevalence of substance use has been estimated
based on a combination of toxicology reports, crime statistics, and selfreported survey questionnaires. The conventional approaches suﬀer
from the high cost, limited coverage, time delays for the prompt need of
intervention, and biases including nonresponse bias and bias in the
selection of sample population with the higher use of drugs (Keshaviah
et al., 2016); therefore, potentially underestimate the actual consumption of drugs. WBE is a comprehensive, cost-eﬀective, and nearreal-time approach that can be used as an early warning system for the
prevalence of substance use or public health. However, there are several methodological uncertainties associated with the WBE: analytical
uncertainties such as the selection of sampling period, sampling
method, storage, sample pre-treatment, extraction, and quantiﬁcation
as well as the uncertainties corresponding to the parameters that are
considered for back-calculation such as wastewater inﬂow, stability of
drugs in wastewater, pharmacokinetics of the biomarker, and the population served by the wastewater treatment plant (WWTP) (Subedi,
2019; Castiglioni et al., 2013).
The stability kinetics of a drug in wastewater depends on the
complexity of wastewater matrix, the residence time, temperature, and
pH (Subedi, 2019). There is a wide-range of stability of drugs reported
at varied experimental conditions such as the time period (12 h, 24 h,
72 h, etc.), temperature (-20 °C to 20 °C), pH (1.8–7.5), and spiking
levels of drugs (60–1000 ng/L) (Table S1) (van Nuijs et al., 2012; Baker
and Kasprzyk-Hordern, 2011). Similarly, the pharmacokinetics depends
on the routes of drug administration, habits of consumption, dose
amount, duration of drug administration, and individuals’ metabolism
(Table S2) (Khan and Nicell, 2011). For instance, the estimated national
prevalence of cocaine consumption based on an average rate of excretion was underestimated by 29% when considering nasal insuﬄation
and by 182% when considering smoking as a primary mode of consumption compared to an estimate based on the constructed excretion
proﬁle of cocaine incorporating all potential routes of administration
(nasal, insuﬄation, smoking, injection, and oral ingestion).

2. Materials and methods
2.1. Sample collection and preparation
Two WWTPs from two adjoined urban communities in eastern
Kentucky were sampled for seven consecutive days during a typical
week in late summer of 2018. Twenty-four-hour composite samples of
raw wastewater (one aliquot every 15 min) were collected using a time2
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proportional autosampler and maintained at 4 °C during the collection
period. According to the WWTP facility operators, WWTPA serves a
population of ˜190,000 people (60% of the city) and treats an average
of 27.2 million gallons per day (MGD) of sewage from industrial and
metropolitan areas. WWTPB serves a population of ˜150,000 people and
treats an average of 21 MGD of sewage from more suburban areas. All
collected samples were transported on ice to the laboratory and extracted within six hours of collection.
The detailed sample preparation procedures are described elsewhere (Foppe et al., 2018; Skees et al., 2018). Brieﬂy, the collected
samples were allowed to equilibrate to room temperature, thoroughly
mixed, centrifuged 100 mL of wastewater at 4500 rpm for 5 min, and
vacuum ﬁltrated using glass ﬁber ﬁlter paper (1.2 μm, 4.25 cm diameter) to separate suspended particulate matter (SPM). Filtered samples were spiked with internal standards mixture (containing 50–150 ng
of each analyte) and extracted using Oasis® hydrophilic-lipophilic balance (HLB) solid phase extraction (SPE) cartridges. Cartridges were
conditioned with 3 mL of methanol followed by 3 mL of ultrapure water
prior extraction. The spiked samples were passed through SPE cartridges at a ﬂow rate of ˜1 mL/min, catridges were dried under vacuum
for ˜5 min, and stored at -20 °C for a week until elution. Cartridges were
allowed to reach ambient temperature and then eluted with 4 mL of
methanol followed by 3 mL of 5% ammonia in methanol. The extracts
were combined and concentrated to ˜250 μL under a gentle stream of
nitrogen at ambient temperature. The concentrate was transferred
quantitatively to an amber silanized HPLC vial and the ﬁnal volume
was adjusted to ˜1 mL with methanol. SPM was freeze-dried for ˜6 h,
allowed to reach room temperature, spiked with the internal standard
mixture, vortexed with 6 mL of methanol, and ultra-sonicated for
30 min. SPM samples were then centrifuged at 4500 rpm for 5 min and
the supernatant liquid was collected. The SPM samples were re-extracted with another 6 mL of methanol and the extracts were combined.
Extracted samples were then concentrated to ˜250 μL under a gentle
stream of nitrogen, quantitatively (several methanol rinses) transferred
to amber silanized HPLC vials, and adjusted the ﬁnal volume to ˜1 mL
with methanol. All prepared samples were subjected to ultra-performance liquid chromatography (UPLC) tandem mass spectrometry (MS/
MS) analysis of target drug residues (Supporting Info).

Table 1
Population in WWTP catchments.
Communities

Census
Population*

NH4-N (mg/d)**

NH4-N-based
Population**

Urban A
Urban B
Rural

190,000
150,000
20,000

13.1 ± 1.2
14.1 ± 1.6
9.82 ± 0.34

189,335 ± 12,757
157,796 ± 20,187
21,835 ± 1742

*provided by the WWTP operators; **average ± standard error.

2.3. Estimation of population
Three candidate hydrochemical markers: ammoniacal nitrogen
(NH4-N), total phosphorous, and biological oxygen demand (BOD) are
assessed for their suitability to estimate the size of the population (Eq.
(1)).

Pi, j =

CBi × Fj
R Bi

i = 1, 2, 3 and j = 1,21…...7

(1)

where CBi is the concentration of a hydrochemical marker (mg/L)
(Table S3), Fj is the wastewater inﬂow (L/d) for the jth day, and R Bi is an
average per capita daily production of the ith hydrochemical marker
(NH4-N: 6900 mg/d (Been et al., 2014); phosphorous: 1700 mg/d (van
Nuijs et al., 2011); and BOD: 5900 mg/d (van Nuijs et al., 2011)). The
estimated population using these markers varied considerably during
seven days of the sampling period (Fig. S1). Overall, NH4-N based population (Table 1) was found more reliable (RSD: 18%, n = 7) compared to the total phosphorus (RSD: 21%, n = 7) and BOD-based populations (RSD: 36%, n = 7) in urban A; therefore, it was considered to
estimate the prevalence of substance uses in this study. Though more
accurate, NH4-N based population still subject to have uncertainty and
is accounted through uncertainty analysis discussed in Section 2.5.
2.4. Estimation of the consumption rate of drugs
The mass load and the consumption rate of target drugs were determined using Eqs. (2) and (3) similar as described elsewhere (Foppe
et al., 2018; Subedi and Kannan, 2014; Skees et al., 2018).

Mass load = (C ± SC ) × (F ± SF ) ×
2.2. Isotope dilution liquid chromatography-tandem mass spectrometry

×
The prepared samples were analyzed for target drug residues using
UPLC (Agilent 1290 Inﬁnity II LC System) coupled with Triple
Quadrupole mass spectrometer (Agilent 6460) (Santa Clara, CA). The
gradient ﬂow of HPLC grade methanol and 0.1% aqueous solution of
formic acid were used to separate analytes using a Force Biphenyl
chromatographic column (100 mm × 2.1 mm i.d. × 1.8 μm particle
size). Target analyte’s peak identiﬁcation was based on the relative
retention time ( ± 0.05 min) to their standard solution, two parent-todaughter ions transitions, and the ratio of the abundance of quantitative
to qualitative ions ( ± 20%) (Skees et al., 2018). The isotopic dilution
mass spectrometry method was applied where a known quantity of
deuterated isotopes of each target analyte (internal standard) is spiked
directly into the sample before sample preparation and analytes are
quantiﬁed based on the relative response factors of isotopic-labeled
internal standard and the corresponding analyte. This method allows
for accurate quantiﬁcation by correcting for the loss of analytes during
the sample preparation and instrumental analysis process. The ﬁve-toten-point calibration curves of each target analyte were prepared by
plotting the concentration-dependent response factor against the response dependent concentration factor. The linear or quadratic (four
analytes) regression coeﬃcients determined using Agilent MassHunter
Workstation for the Quantitative Analysis were r2 ≥0.99 for all analytes. The details of quality assurance and quality controls are provided
in supporting information.

100
[100 + (Stability + Sstability )]

1
1 × 106

(2)

100
]
(Ex ± SEx
MWpar
1000
×[
]×[
]
MWmet
(Pop ± SPop)

Consumption/1000 people = [Mass Load ± SML] × [

(3)

where mass load is the amount of individual illicit drugs introduced into
WWTP (mg/d), C is the total nanograms of analytes in 1 L of wastewater
inﬂuent and SPM combined (ng/L), F is the daily ﬂow rate of wastewater inﬂuent (L/d) over a 24 h period, and stability is a measure of
stability change (%) of analyte in wastewater up to 12 h (Table S1). SC
and SF are the standard errors associated with the estimated sample
mean concentration of drugs and the wastewater inﬂow, respectively.
Similarly, consumption rate of drugs was determined as the milligrams
of drugs per 1000 people, Ex is the percentage excretion rates (Table
S2), MWpar is the molar mass of parent drug, MWmet is the molar mass of
metabolite, Pop is an estimated population size based on NH4-N load in
the raw wastewater. The SML, SEx, SPop are the standard errors associated with the estimated average mass load, reported excretion rates,
and the estimated population, respectively. The mass loadings and the
cosnumption rates of cocaine, heroin, methadone, and THC were determined based on the residual levels of their stable metabolites in the
wastewater: benzoylecgonine, 6-acetyl morphine, EDDP, and THCA,
respectively. The mass loading and the consumption rate of all other
3
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methamphetamine, and methylphenidate was statistically equivalent.
(Table 2 and Fig. 1). Accounting several individual uncertainties in
WBE estimation, Lai et al. (2011) also reported several hundred milligrams of daily consumption of cocaine, methamphetamine, and MDMA
per 1000 people daily in a vibrant urban community (population
˜300,000–350,000) in South East Queensland, Australia (Lai et al.,
2011).
Similarly, among nine potentially abused opioids/narcotics, the
hydromorphone consumption in urban A (67 mg/d/1000 people) was
found signiﬁcantly higher (MD: 27 mg/d/1000 people) than in urban B.
The buprenorphine was consumed most in both communities
(˜1600 mg/d/1000 people) followed by oxycodone (˜500 mg/d/1000
people) among the prescribed narcotics. In fact, the prescription doses
of buprenorphine and oxycodone in these communities were the
highest in Kentucky (Kentucky All Schedule Prescription Electronic
Reporting, 2018).
Recently, fentanyl overdose death rates (52% of total overdose
deaths) surpassed the heroin-related as well as the prescription opioidrelated deaths in Kentucky (Kentucky Injury Prevention and Research
Center, 2019). The fentanyl and heroin-related overdose deaths in
urban A and B were among the highest in the state (Kentucky Oﬃce of
Drug Control Policy, 2017). In this study, the prevalence of fentanyl and
heroin abuse were similar in both urban communities. Although the
prevalence of cocaine abuse and hydromorphone use was signiﬁcantly
higher in the central business district, the consumption rate of prescribed psychoactive drugs such as carbamazepine [1580 (MD: 835)
mg/d/1000 people] and temazepam [benzodiazepine of potential
abuse, 37 (MD: 21) mg/d/1000 people] were signiﬁcantly higher in
urban B.

drugs were determined utilizing the residual concentrations of their
unchanged parent drugs in wastewater.
2.5. Uncertainty treatment using Monte Carlo simulation
All input variables used in the Eqs. (2) and (3) are measured with
the error or reported with inherent uncertainty. Consequently, estimates from back-calculations subject to various uncertainties associated
with diﬀerent variables or diﬀerent steps involved or both. Additionally, the formula used for determining mass loading and the
consumption rates are not a linear function of the individual parameters
used, and thus the errors associated with the estimates are not trackable
analytically. As the calculation became more complex, a more general
approach is needed to account uncertainties (Jones et al., 2014).
In this study, we implemented a Monte Carlo (MC) simulation to
account multiple sources of uncertainty associated with the individual
parameters involved in WBE estimations. The MC is a computing algorithm to draw repeated random sampling from a given probability
distribution and oﬀers powerful tools to model propagation of the uncertainties. For implementing MC methods, all parameters involved in
the back-calculation (Eqs. (2) and (3)) are assumed to have a normal
distribution with an estimated value of the parameter as the mean and
associated standard error of the estimate to the standard deviation of
the distribution (see tables S1, S2, S3, and S4 for the sample mean and
associated standard error). For drugs with only one reported value for
stability and excretion rate, the same value was used in all MC samples
while performing back calculations. Individual values of the input
parameter are then randomly generated from the assumed normal
distribution, and the simulated values of the input parameters are later
used in the back calculations. The use of these repeated random samples of input parameter in the back calculations generate simulated
values for the variable of interest such as mass loading and the consumption rates. The values obtained from the back calculations are used
to ﬁnd the point estimates and conﬁdence interval for the parameter
such as average mass loading and average per capita consumption rates.
Additionally, for comparing prevalence of the substance use in three
communities, mean diﬀerence (MD), as well as 95% conﬁdence interval
for MDs, are constructed. A 95% conﬁdence interval for a true parameter is interpreted as a range in which there is a 95% probability that
the true parameter lies. Two communities are considered signiﬁcantly
diﬀerent at the 5% signiﬁcance level if a 95% conﬁdence interval (CI)
for the MD does not contain zero.

3.2. Prevalence of drug consumption between urban and rural communities
The median per-capita income of a rural community ($17,650) was
1.8 times lower than in urban A and B (United States Census Bureau,
2019). The estimated average population of rural, urban A, and urban B
communities were 21,835 ± 1742, 189,335 ± 12,757, and
157,796 ± 20,187, respectively, based on ammoniacal nitrogen load
in raw wastewater for a week (Table 1). Our research group reported
the consumption rates of several drugs from a rural community in
western Kentucky (Skees et al., 2018). The reported consumption rate
of drugs in a rural community in western Kentucky, after incorporating
the potential uncertainties in WB-epidemiological estimation, is hereby
compared to that found at two urban communities.
The prevalence of cocaine consumption was signiﬁcantly higher in
urban communities compared to a rural community whereas the consumption rates of amphetamine and methylphenidate are signiﬁcantly
higher in the rural community (Table 2, Fig. 2). One-day equivalent
dose of cocaine costs approximately $110 while the amphetamine/
methamphetamine cost $40 per day (Postigo et al., 2008; Department
of Consumer Protection, 2019; RehabCenter.net, 2019). In Australia, a
WBE study that involved WWTPs serving 40% of the continent’s population found that the cocaine consumption in urban areas was higher
than rural areas by up to two orders of magnitude (Lai et al., 2016).
In contrast to the present study, the majority of recent WBE studies
have found that methamphetamine consumption is similar in both
urban and rural areas with no clear geographical pattern (Lai et al.,
2016; Du et al., 2015). Thomas et al. found an inverse relationship
between cocaine and methamphetamine prevalence in a study comparing 19 European cities, in which Finland, Norway, and the Czech
Republic had low rates of cocaine consumption but the highest rates of
methamphetamine use (Thomas et al., 2012). In the Midwest U.S.,
particularly western Kentucky, the clandestine methamphetamine laboratories are historically more prevalent (National Drug Intelligence
Center, 2019; United States Drug Enforcement Agency, 2019). Therefore, the relative lower cost and accessibility of methamphetamine/
amphetamine can have resulted in a higher prevalence in the rural

3. Results and discussion
Seven residual illicit drugs and sixteen prescribed psychoactive
drugs were detected in 100% of the collected wastewater samples from
two WWTP in urban communities (Table S4). Benzoylecgonine, a cocaine metabolite, dominates the illicit drug proﬁle while antidepressants dominate the prescribe psychoactive drug levels in wastewater.
3.1. Drug consumption in two adjoined urban communities
Urban communities include one of the most educated (> 43.6% of
people have at least college education) and lively (˜40% population
adults) cities in the country. The urban community A (urban A hereinafter) in Eastern Kentucky comprises the central business district,
downtown, industrial, and the University area. Similarly, the adjoined
community B (urban B hereinafter) is a fast-growing suburban area.
Table 2 presents the mean consumption rate, MD of the consumption rates and associated 95% CI. The mean per-capita consumption
rate of cocaine in the central business district (urban A: 3830 mg/d/
1000 people) was found signiﬁcantly higher (MD: 1980 mg/d/1000
people) than in urban B (1850 mg/d/1000 people) while the consumption rate of other stimulants such as amphetamine,
4
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Table 2
Consumption rate of drugs in urban A, urban B, and a rural community in Kentucky, U.S. The values in parenthesis represent the 95% conﬁdence interval.
Analytes

Stimulants
Cocaine (CCN)*
Cocaine**
Amphetamine (AMP)
Methamphetamine (MAPT)
Methylphenidate (MPD)
Opioids/Narcotics
Heroin* (HER)
Morphine (MPH)
Methadone* (MTD)
Methadone**
Codeine (CDN)
Fentanyl (FNT)
Oxycodone (OCD)
Hydrocodone (HCD)
Hydromorphone (HMP)
Buprenorphine (BPN)
Hallucinogens
MDMA
MDEA
MDA
THC*
Antischizophrenics
Quetiapine (QTP)
Sedatives-Hypnotics-Anxiolytics
Lorazepam (LZP)
Alprazolam (APZ)
Diazepam (DZP)
Oxazepam (OXZ)
Temazepam (TMZ)
Carbamazepine (CRB)
Antidepressants
Sertraline (SRT)
Fluoxetine (FLX)
Venlafaxine (VNF)
Citalopram (CTP)

Consumption Rate (mg/d/1000 people)
(95% Conﬁdence Interval)

Mean diﬀerence
(95% Conﬁdence Interval)

Urban A

Urban B

Rural

Urban A - Urban B

Urban A - Rural

Urban B - Rural

3830 (2850, 5060)
2790 (2040, 3710)
400 (279, 556)
1030 (721, 1400)
284 (185, 398)

1850 (1170, 2780)
1180 (748, 1760)
344 (208, 535)
1160 (694, 1790)
290 (198, 415)

864 (471, 1440)
363 (199, 603)
738 (446, 1100)
1660 (985, 2460)
605 (372, 885)

1980 (785, 3250)
1610 (698, 2600)
344 (208, 535)
1160 (694, 1790)
−6 (-163, 142)

2960 (1920, 4200)
2430 (1650, 3350)
−338 (-677, -43)
−629 (-1430, 81)
−321 (-616, -62)

984 (149, 1970)
816 (332, 1430)
−393 (-748, -78)
−276 (-1260, 581)
−315 (-611, -50)

1620 (961, 2700)
312 (208, 452)
106 (65, 178)

1810 (600, 3610)
229 (140, 357)
92 (53, 160)

n/a
99 (54, 167)
1410 (708, 2600)

−187 (-1730, 1130)
83 (-46, 214)
14 (-31, 60)

n/a
130 (34, 254)
−1317 (-2490, -635)

449 (289, 716)
50 (31, 86)
169 (85, 391)
566 (272, 1060)
166 (126, 213)
67 (51, 87)
1700 (1220, 2260)

428 (253, 716)
52 (28, 96)
134 (54, 324)
459 (232, 866)
134 (93, 189)
40 (28, 56)
1480 (975, 2150)

NA
192 (87, 388)
31 (13, 72)
465 (217, 919)
507 (289, 820)
142 (82, 226)
3150 (1800, 5030)

21 (-178, 204)
−2 (-32, 21)
35 (-57, 150)
107 (-230, 474)
33 (-35, 95)
27 (4, 51)
219 (-568, 955)

n/a
213 (107, 345)
−1300 (-2450,
-620)
NA
−142 (-320, -44)
138 (66, 327)
101 (-281, 488)
−341 (-657, -118)
−75 (-161, -11)
−1450 (-3370, -2)

28 (19, 40)
25*
6 (5, 8)
88100 (54000134000)

21 (11, 36)
< LOQ
< LOQ
78700 (48500122000)

n/a
n/a
n/a
n/a

7 (-10, 21)
n/a
n/a
9400 (-35500-53200)

n/a
n/a
n/a
n/a

n/a
n/a
n/a
n/a

31 (26, 36)

33 (21, 48)

31 (18, 49)

−2 (-21, 14)

0 (-22,17)

2 (-22, 18)

8 (5, 10)
66 (53, 81)
3 (2, 5)
3 (2, 5)
16 (10, 23)
749 (567, 959)

12 (8, 17)
68 (49, 94)
< LOQ
4 (2, 7)
37 (24, 55)
1580 (1000, 2350)

26 (16, 37)
30 (17, 50)
4 (2, 4)
40 (23, 63)
83 (48, 132)
615 (347, 1000)

−4 (-11, 1)
−2 (-31, 23)
n/a
−1 (-4, 2)
−21 (-40, -6)
−835 (-1620, -217)

−14 (-29, -4)
36 (13, 56)
−1 (-3, 2)
−37 (-60, -20)
−67 (-116, -32)
134 (-289, 479)

−14 (-27, -4)
38 (10, 68)
n/a
−36 (-59, -19)
−46 (-96, -7)
969 (279, 1780)

11700 (7960, 15100)
581 (459, 724)
4750 (3470, 6240)
916 (536, 1600)

14300 (9020, 21400)
787 (547, 1110)
6230 (4200, 8960)
1080 (599, 1940)

4030 (2180, 6730)
210 (115, 349)
5450 (3150, 8720)
1160 (565, 2250)

−2700 (-11600, 4610)
−206 (-547, 73)
−1480 (-4400, 1010)
−159 (-720, 285)

7620 (2550, 12,150)
371 (192, 545)
−705 (-4160, 2020)
−248 (-1060, 323)

10300 (5230, 14000)
577 (304, 923)
775 (-3060, 4350)
−89 (-909, 603)

NA
−140 (-319, -42)
103 (32, 267)
−6 (-367, 325)
−373 (-689, -149)
−102 (-187, -40)
−1670 (-3600, -176)

*based on the concentration of a metabolite; **based on the concentration of residual parent drug; bolds values are signiﬁcantly diﬀerent (range of mean diﬀerence
did not include zero); < LOQ: below the limit of quantitation, n/a: non-applicable.

Fig. 1. The prevalence of select illicit and prescribed neuropsychiatric drugs in two adjoined urban communities. Cocaine* and Methadone* represent the consumption rates determined based on the residual level of the parent cocaine and methadone, respectively, while Heroin* and THC* represent the consumption rates
determined based on the residual level of the metabolites 6-acetyl morphine and THCA, respectively. The prevalence of all other drugs were determined based on the
residual level of their parent drugs.
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Fig. 2. The prevalence of select illicit and prescribed neuropsychiatric drugs in urban A and a rural community. Cocaine* and Methadone* represent the consumption
rates determined based on the residual level of the parent cocaine and methadone, respectively, while Heroin* and THC* represent the consumption rates determined
based on the residual level of the metabolites 6-acetyl morphine and THCA, respectively. The prevalence of all other drugs were determined based on the residual
level of their parent drugs.

of select schedule II through V controlled substance –dispensing in
Kentucky (Jones et al., 2014). Based on the reported prescription doses
per 1000 people in all 120 counties in the state including the study
areas and the typical daily doses (www.rxlist.com), the total amount of
prescribed drugs (milligrams/day) were determined and compared with
the WBE estimates in this study (Fig. 3). The population of urban
communities in this study represents ˜90% of the total population in a
county while the population of a rural community represents approximately two-third of the total population in a county.
The prevalence of alprazolam and oxycodone in urban communities
was ˜3 folds higher than the reported prescriptions-based KASPER estimations (Fig. 3); however, KASPER’s estimations in a rural community
are within 95% conﬁdence interval of WBE estimation. It suggests the
potential abuse of alprazolam and oxycodone in urban communities.
Similarly, buprenorphine is 2–3 orders of magnitude higher prevalent
in urban and rural communities compared to KASPER’s estimation
suggests the potential abuse of buprenorphine in both communities.
Kentucky Injury Prevention and Research Center (KIPRC) issues the
county proﬁles on drug-related inpatient hospitalizations and emergency department visits in Kentucky (Kentucky All Schedule
Prescription Electronic Reporting, 2018). Based on KIPRC’s report in
2018, the drug-related impatient hospitalization and emergency department visits by the dependent and nondependent abusers per 1000
people in urban and rural counties were calculated. The total hospital
visits by the hypnotic-sedative-anxiolytic abusers in urban communities
A and B (0.87/1000 people) were ˜2 folds higher than in a rural community, which is a very close agreement to WBE estimations for alprazolam in this study (Fig. 3). Similarly, hospital visits by the cocaine
abuser’s in urban communities were an order of magnitude higher than
in a rural community which is also supported by the signiﬁcantly higher
consumption rate of cocaine in urban communities in this study.
However, KIPRC estimation of amphetamine abusers in both communities are similar (˜3 per 1000 people) despite a signiﬁcantly higher
consumption rate of amphetamine in the rural community was found in
this study.

community in western Kentucky. Amphetamine and methylphenidate,
schedule II stimulants, are the active ingredients of prescribed drugs
Adderall®, Concerta®, Ritalin®, etc. As the prescription rate of amphetamine and methylphenidate drugs is higher in urban A and B communities (Jones et al., 2014); a signiﬁcantly higher consumption rate of
these drugs in the western rural community suggests additional sources
of amphetamine and methylphenidate. The overall consumption of
schedule II stimulants in Kentucky is predominant (> 2 folds higher)
among individuals age < 34 compared to the individuals > 34 (Jones
et al., 2014), and ˜10% of the total population are current college
students in urban A and B communities while ˜40% of the total population are current college students in the rural community. Therefore,
the diﬀerence in population proﬁle in urban and rural communities can
also have contributed to a diﬀerential consumption rate of amphetamine and methylphenidate.
The opioid overdose resulting > 130 fatalities every day in the U.S.,
and the opioid-related overdose deaths in Kentucky is one of the highest
in the country (National Institute on Drug Abuse, 2019). In this study,
the prevalence of fentanyl and morphine consumptions in urban communities were signiﬁcantly higher than in a rural community while the
prevalence of prescribed opioids such as codeine, hydrocodone, hydromorphone, and buprenorphine consumptions was signiﬁcantly
higher in the rural community (Table 2, Fig. 2). This suggests that the
overall prevalence of opioid consumption in rural communities can be
equally or higher than in urban communities.
Among prescribed psychoactive drugs, alprazolam was found signiﬁcantly higher in urban communities while temazepam, oxazepam,
and lorazepam were found signiﬁcantly higher in the rural community.
The consumption rate of carbamazepine in an urban B was signiﬁcantly
higher [1584 (MD: 969) mg/d/1000 people] than in a rural community. Similarly, the consumption of sertraline, a prescribed antidepressant, in urban communities was 2–3 folds higher than in the rural
community.

3.3. WBE-derived vs conventional estimates of the prevalence of substance
uses

3.4. Need for the evidence-based prevalence of substance uses
The statewide controlled substance prescription monitoring system,
Kentucky All Schedule Prescription Electronic Reporting (KASPER),
reports a threshold analysis report based on the conventional estimate

As it has been demonstrated herein and several other studies, the
conventional approaches typically underestimate the actual prevalence
6
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Fig. 3. Comparison between the KASPER’s conventional estimation and the WBE estimation of select substances of potential abuse. The bars represent a 95% conﬁdence interval of
the WBE-derived mean consumption rate while KASPER’s estimates are marked as red dotted lines. (For interpretation of
the references to colour in this ﬁgure legend, the reader is
referred to the web version of this article).
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